|

Placebo IV Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: Toripalimab placebo

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Shanghai Junshi Bioscience Co., Ltd.1
  • Eli Lilly and Company1

Indications

  • Diabetes Mellitus, Type 11
  • Diabetes1
  • Healthy1
  • Intrahepatic Cholangiocarcinoma1
  • Diabetes Mellitus, Type 21

Other2 trials

A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
Phase 1
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.